Toggle navigation
Home
Search
Services
Blog
Contact
About
Enzymes of OMEGA-3 Fatty Acid Biosynthesis
Kyle, David J.
Martek Bioscience Corporation, Columbia, MD, United States
Search 49 grants from David Kyle
Search grants from Martek Bioscience Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Haptic Sensory Glove for Humans and Robots
Research Training for Cancer Epidemiology &Biostatistics in China
Micro-Instrument Platforms for Genetic-Based Analyses
DNA Methyltransferase Gene Expression in Colon Cancer
Periodic Error Elimination Through New Displacement Measuring Interferometer Design
Recently added grants:
Genetic Analysis of Myeloproliferative Disease
Successive responses to oncogenic aberrations in retinoblastoma genesis.
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients
Improving treatment of cardiovascular risk factors in childhood cancer survivors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44FD001448-03
Application #
3507733
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1989-09-30
Project End
1991-09-29
Budget Start
1990-09-30
Budget End
1991-09-29
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
Martek Bioscience Corporation
Department
Type
DUNS #
City
Columbia
State
MD
Country
United States
Zip Code
21045
Related projects
NIH 1990
R44 FD
Enzymes of OMEGA-3 Fatty Acid Biosynthesis
Kyle, David J. / Martek Bioscience Corporation
NIH 1989
R44 FD
Enzymes of OMEGA-3 Fatty Acid Biosynthesis
Kyle, David J. / Martek Bioscience Corporation
Comments
Be the first to comment on this grant